New hope for tough pancreatic cancer: targeted nanocells join chemo battle
Disease control
Recruiting now
This study tests whether adding a new targeted treatment (E-EDV-D682/GC) to standard chemotherapy can help people with metastatic pancreatic cancer live longer. The new treatment uses tiny particles called nanocells to deliver a powerful drug directly to cancer cells. About 144 a…
Phase: PHASE1, PHASE2 • Sponsor: Engeneic Pty Limited • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC